146 related articles for article (PubMed ID: 30638389)
1. Evaluation Efficacy of Rhenium-188-Loaded Micro-particles for Radiotherapy in a Mouse Model of Hepatocellular Carcinoma.
Shih YH; Peng CL; Weng MF; Chiang PF; Luo TY; Lin XZ
Mol Pharm; 2019 Mar; 16(3):1083-1091. PubMed ID: 30638389
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and application of 188Re-MN-16ET/Lipiodol in a hepatocellular carcinoma animal model.
Tang IC; Luo TY; Liu SW; Chan SH; Kung HC; Peng CL; Lin WY; Chang Y; Lin WJ
Nucl Med Biol; 2011 Oct; 38(7):1043-52. PubMed ID: 21831647
[TBL] [Abstract][Full Text] [Related]
3. Biodistribution and pharmacokinetics of 188Re-liposomes and their comparative therapeutic efficacy with 5-fluorouracil in C26 colonic peritoneal carcinomatosis mice.
Tsai CC; Chang CH; Chen LC; Chang YJ; Lan KL; Wu YH; Hsu CW; Liu IH; Ho CL; Lee WC; Ni HC; Chang TJ; Ting G; Lee TW
Int J Nanomedicine; 2011; 6():2607-19. PubMed ID: 22114492
[TBL] [Abstract][Full Text] [Related]
4. DA-7911, 188Rhenium-tin colloid, as a new therapeutic agent of rheumatoid arthritis.
Shin CY; Son M; Ko JI; Jung MY; Lee IK; Kim SH; Kim WB; Jeong JM; Song YW
Arch Pharm Res; 2003 Feb; 26(2):168-72. PubMed ID: 12643596
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic and scintigraphic applications of polymeric micelles: combination of chemotherapy and radiotherapy in hepatocellular carcinoma.
Shih YH; Peng CL; Chiang PF; Lin WJ; Luo TY; Shieh MJ
Int J Nanomedicine; 2015; 10():7443-54. PubMed ID: 26719687
[TBL] [Abstract][Full Text] [Related]
6. Biodistribution, Pharmacokinetics and Efficacy of
Chen LC; Lee WC; Ho CL; Chang YJ; Chen SJ; Chang CH
In Vivo; 2018; 32(3):567-573. PubMed ID: 29695562
[TBL] [Abstract][Full Text] [Related]
7. Evaluating the potential of (188)Re-ECD/lipiodol as a therapeutic radiopharmaceutical by intratumoral injection for hepatoma treatment.
Luo TY; Shih YH; Chen CY; Tang IC; Wu YL; Kung HC; Lin WJ; Lin XZ
Cancer Biother Radiopharm; 2009 Oct; 24(5):535-41. PubMed ID: 19877883
[TBL] [Abstract][Full Text] [Related]
8. Preparation and biodistribution of 188Re-labeled folate conjugated human serum albumin magnetic cisplatin nanoparticles (188Re-folate-CDDP/HSA MNPs) in vivo.
Tang QS; Chen DZ; Xue WQ; Xiang JY; Gong YC; Zhang L; Guo CQ
Int J Nanomedicine; 2011; 6():3077-85. PubMed ID: 22163161
[TBL] [Abstract][Full Text] [Related]
9. Preparation and therapeutic evaluation of (188)Re-thermogelling emulsion in rat model of hepatocellular carcinoma.
Shih YH; Lin XZ; Yeh CH; Peng CL; Shieh MJ; Lin WJ; Luo TY
Int J Nanomedicine; 2014; 9():4191-201. PubMed ID: 25214783
[TBL] [Abstract][Full Text] [Related]
10. Imaging, biodistribution and efficacy evaluation of
Chen LC; Chang YJ; Chen SJ; Lee WC; Chang CH; Lee TW; Shien JH
Int J Radiat Biol; 2017 May; 93(5):477-486. PubMed ID: 28045339
[TBL] [Abstract][Full Text] [Related]
11. Preparation and imaging of rhenium-188 labeled human serum albumin microsphere in orthotopic hepatoma rats.
Ni HC; Yu CY; Chen SJ; Chen LC; Lin CH; Lee WC; Chuang CH; Ho CL; Chang CH; Lee TW
Appl Radiat Isot; 2015 May; 99():117-21. PubMed ID: 25748057
[TBL] [Abstract][Full Text] [Related]
12. Two Cases of 188Re Microspheres for Inoperable Hepatocellular Carcinoma.
Shukla J; Kalra N; Kumar R; Bhusari P; Chhabra A; Parmar M; Vatsa R; Singh H; Duseja A; Mittal BR
Clin Nucl Med; 2019 Feb; 44(2):e93-e95. PubMed ID: 30418210
[TBL] [Abstract][Full Text] [Related]
13. Biokinetic and dosimetric studies of 188Re-hyaluronic acid: a new radiopharmaceutical for treatment of hepatocellular carcinoma.
Meléndez-Alafort L; Nadali A; Zangoni E; Banzato A; Rondina M; Rosato A; Mazzi U
Nucl Med Biol; 2009 Aug; 36(6):693-701. PubMed ID: 19647176
[TBL] [Abstract][Full Text] [Related]
14. Establishment of a human hepatocellular carcinoma cell line highly expressing sodium iodide symporter for radionuclide gene therapy.
Kang JH; Chung JK; Lee YJ; Shin JH; Jeong JM; Lee DS; Lee MC
J Nucl Med; 2004 Sep; 45(9):1571-6. PubMed ID: 15347726
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic efficacy of 188Re-MN-16ET lipiodol in an animal model of hepatocellular carcinoma.
Huang PW; Tsai SC; Luo TY; Kao CH; Lin WY
Ann Nucl Med; 2013 Jul; 27(6):532-7. PubMed ID: 23479326
[TBL] [Abstract][Full Text] [Related]
16. Feasibility of high activity rhenium-188-microsphere in hepatic radioembolization.
Liepe K; Brogsitter C; Leonhard J; Wunderlich G; Hliscs R; Pinkert J; Folprecht G; Kotzerke J
Jpn J Clin Oncol; 2007 Dec; 37(12):942-50. PubMed ID: 18094017
[TBL] [Abstract][Full Text] [Related]
17. Development of in situ forming thermosensitive hydrogel for radiotherapy combined with chemotherapy in a mouse model of hepatocellular carcinoma.
Peng CL; Shih YH; Liang KS; Chiang PF; Yeh CH; Tang IC; Yao CJ; Lee SY; Luo TY; Shieh MJ
Mol Pharm; 2013 May; 10(5):1854-64. PubMed ID: 23485019
[TBL] [Abstract][Full Text] [Related]
18. Radioembolization of Hepatocellular Carcinoma with Built-In Dosimetry: First
De La Vega JC; Esquinas PL; Rodríguez-Rodríguez C; Bokharaei M; Moskalev I; Liu D; Saatchi K; Häfeli UO
Theranostics; 2019; 9(3):868-883. PubMed ID: 30809314
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic efficacy of a 188Re-labeled alpha-melanocyte-stimulating hormone peptide analog in murine and human melanoma-bearing mouse models.
Miao Y; Owen NK; Fisher DR; Hoffman TJ; Quinn TP
J Nucl Med; 2005 Jan; 46(1):121-9. PubMed ID: 15632042
[TBL] [Abstract][Full Text] [Related]
20. Rhenium-188: availability from the (188)W/(188)Re generator and status of current applications.
Pillai MR; Dash A; Knapp FF
Curr Radiopharm; 2012 Jul; 5(3):228-43. PubMed ID: 22642385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
